United States
Lan Ting Capital is a cross-border, pharmaceutical focused strategic consulting and investment firm. Founded by pharmaceutical veterans and asset management experts, LTC leverages our unparalleled industry knowledge and network plus deep financial market know-how across the US, China and Europe to unlock unique cross-border growth opportunities for our portfolio companies and investors. Find More, Please Email: [email protected]
12
Total Investments
11
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Financial Services, Health Care
Company Overview
About Lanting Capital
Recent Investments (12)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Venture Round | •••••• | Jul 2022 | |
| Series A | •••••• | Apr 2022 | |
| Series B | •••••• | Feb 2021 | |
| Series C | •••••• | Jan 2021 | |
| Series C | •••••• | Dec 2020 | |
•••• ••••
|
Series F | •••••• | Nov 2020 |
|
•••• ••••
|
Series A | •••••• | Nov 2018 |
|
•••• ••••
|
Series A | •••••• | Feb 2018 |
|
•••• ••••
|
Series A | •••••• | Nov 2017 |
|
•••• ••••
|
Series B | •••••• | Oct 2016 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
